A new study shows that patients who initiated treatment with blood pressure or cholesterol medications were more likely to reduce activity and gain weight.
Are the benefits of lowering systolic blood pressure to less than 130 mm Hg the same for those aged 80 years and older as they are for younger patients?
AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.
Invasive methods did not perform better than drug treatment in patients with stable ischemic heart disease
Officials with the FDA have approved a new indication and label expansion for icosapent ethyl (Vascepa, Amarin).
Pharmacist-led initiatives, such as medication therapy management, for chronic diseases can significantly improve patient outcomes.
Could lead to falsely high or low results, especially troponin assays.
Statin regimens may need tweaking to deliver optimal results.
Regular exercise can be an effective way to delay the onset and acceleration of COPD.
Results presented at the 2019 NCPA Annual Convention